Wednesday, June 10, 2026
🇺🇸 FDA

Drug profile · INN

recombinant

recombinant is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 149
News articles 0
Drug details — recombinant
Class
—
Route
—
Patents
20
Programs
149
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

recombinant is an FDA-listed pharmaceutical active ingredient.

Key facts

INN recombinant

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. 060103 Phase 3 · Takeda · Hemophilia A
  2. 061002 Phase 3 · Takeda · Hemophilia A
  3. 2024/4031 Phase 3 · George Institute for · Patients with primary HPV high-grade squamous intra-epitheli
  4. 212496 Phase 3 · GSK Glaxo Smith · Respiratory Syncytial Virus Infections
  5. 217848 Phase 3 · GSK Glaxo Smith · Respiratory Syncytial Virus Infections
  6. 222090 Phase 3 · GSK Glaxo Smith · Respiratory Syncytial Virus Infections
  7. 222253 Phase 3 · GSK Glaxo Smith · Respiratory Syncytial Virus Infections
  8. 241502 Phase 3 · Takeda · Hemophilia A

Related patents

Browse patents

  1. WO 2026104630

    MÉTHODE DE SÉLECTION DOMINANTE PERMANENTE POUR LA GÉNÉRATION DU VIRUS ANKARA DE LA VACCINE MODIFIÉ RECOMBINANT (MVA)

    Expires Wed May 16 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12365930

    Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12344676

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12296004

    Recombinant virus with diminished latency and methods of using same

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12292441

    Recombinant Acinetobacter baumannii strain AB5075

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12258372

    Recombinant vaccine against Marek's disease and Newcastle disease

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12233124

    Recombinant metapneumovirus f proteins and their use

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12209256

    System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12209116

    Recombinant human C1 esterase inhibitor and uses thereof

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12188039

    Recombinant adeno-associated viral vector for gene delivery

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 2025002606

    Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVA

    Expires Wed Dec 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12162910

    Recombinant gp120 protein with V1-loop deletion

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12145968

    Recombinant HIV-1 envelope proteins and their use

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12128090

    Methods of prophylactic treatment using recombinant VWF (rVWF)

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12128122

    Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12121567

    Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12108745

    Rat model of IgA nephropathy induced with a multimeric recombinant IgA fragment

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12091463

    Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12091675

    Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. WO 2024149832

    SARNA (VRP) MODIFIÉ RECOMBINANT POUR VACCIN CONTRE LE CANCER

    Expires Wed Jul 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is recombinant?

recombinant is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.